All In Biotech

Free tool

FAERS Monitor: Opipza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216655 or its brand name (Opipza, Aripiprazole). Reports on generic versions are filed under their own applications.

Reports

42,264

Serious

35,961

85% of reports

Hospitalization

16,723

Death reported

3,404

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,421
  • off label use2,952
  • drug interaction2,286
  • product use in unapproved indication2,270
  • weight increased2,162
  • anxiety1,796
  • condition aggravated1,712
  • suicide attempt1,582
  • fatigue1,545
  • suicidal ideation1,449
  • toxicity to various agents1,429
  • nausea1,385
  • somnolence1,363
  • sedation1,318
  • schizophrenia1,305

Reports by year received

View as table
YearReports
200468
2005111
2006161
2007217
2008192
2009256
2010342
2011354
2012534
2013428
2014584
20151,211
20161,456
20172,955
20183,363
20193,484
20203,049
20213,704
20223,702
20234,151
20244,228
20254,180
20263,534

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
schizophreniaSignal1,30559.856.567,286
sedationSignal1,31826.324.930,501
suicide attemptSignal1,58213.312.717,573
suicidal ideationSignal1,4498.07.68,749
drug interactionSignal2,2867.37.012,250
weight increasedSignal2,1624.84.66,593
product use in unapproved indicationSignal2,2704.64.46,389
toxicity to various agentsSignal1,4294.24.03,539
somnolenceSignal1,3633.43.22,294
anxietySignal1,7963.23.02,659
condition aggravatedSignal1,7122.82.72,016
off label use2,9521.71.6844
drug ineffective4,4211.71.61,268
fatigue1,5451.00.90
nausea1,3850.90.827

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.